CoChat

Influence of microalbuminuria in achieving blood pressure goals

Duka, Irena, Bakris, George · 2008 · Current Opinion in Nephrology and Hypertension

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

PURPOSE OF REVIEW: In all individuals with hypertension regardless of diabetes status, microalbuminuria is an independent risk marker for cardiovascular events including myocardial infarction, stroke and other conditions. While blood pressure reduction is important in reducing this marker in individuals with hypertension other factors such as salt intake play an important role in reducing oxidant stress and other factors related to the genesis of microalbuminuria. RECENT FINDINGS: Clinical trials demonstrate that drugs interfering with the renin-angiotensin system--angiotensin-converting enzyme inhibitors and angiotensin receptor blockers--should be used as first-line antihypertensive therapy in patients with microalbuminuria because they seem to have a blood pressure-independent antiproteinuric effect. A combination of an angiotensin-converting enzyme inhibitor with an angiotensin receptor blocker or other classes of medications shown to decrease protein excretion, such as nondihydropyridine calcium antagonists or aldosterone receptor blockers, should be considered to decrease albuminuria further; beta-blockers with alpha-blocking properties such as carvedilol have also been shown to reduce microalbuminuria probably secondary to its antioxidant properties. SUMMARY: This review provides a summary of current evidence regarding the associations of blood pressure with microalbuminuria, the rationale for currently recommended blood pressure goals, and the use of various classes of antihypertensive agents in proteinuric patients.

Overview

Integrity signals

Registry

Crossref · 10.1097/mnh.0b013e328309a497

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 54 references

Research works printed but not linked: 1

  1. Spangler, 1997, J Am Board Fam Pract, 10, 180

Cited by

See all 18

Metadata

Authors
Duka, I., & Bakris, G.
Affiliations
University of Chicago (US)
Corresponding author
Bakris, George
Venue
Current Opinion in Nephrology and Hypertension
Published
2008-09
Volume
17
Issue
5
Pages
457-463
ISSN
1062-4821 (ISSN-L)
OpenAlex
W2022552502
Cited by
18
References
54
Citations by year
2025: 1 · 2023: 3 · 2016: 1 · 2013: 2 · 2012: 1
FWCI
0.50
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Nephrology & Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
microalbuminuria, blood pressure targets, hypertension, renin-angiotensin system, ACE inhibitors, angiotensin receptor blockers, antiproteinuric effect, salt intake, oxidative stress, aldosterone receptor blockers, carvedilol, beta-blockers, antihypertensive therapy, cardiovascular risk
MeSH terms
Albuminuria, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Humans, Hypertension, Risk Factors, Angiotensin Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of microalbuminuria in achieving blood pressure goals. https://app.cochat.ai/papers/10.1097/mnh.0b013e328309a497
The paper
Duka, I., & Bakris, G. (2008). Influence of microalbuminuria in achieving blood pressure goals. Current Opinion in Nephrology and Hypertension. https://doi.org/10.1097/mnh.0b013e328309a497

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.